G-protein-coupled receptor regulators and methods of use thereof
US-2024417378-A1 · Dec 19, 2024 · US
Methods of using as analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds
US9278943B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9278943-B2 |
| Application number | US-201213450854-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 19, 2012 |
| Priority date | Jan 26, 2005 |
| Publication date | Mar 8, 2016 |
| Grant date | Mar 8, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The compounds shown by the structural formulas below have analgesic effect and are used in compositions and methods for treating mammal in need of such treatment.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating pain in a mammal in need of such treatment, comprising administering to said mammal a compound selected from the group consisting of the compounds shown by structural formulas below or any pharmaceutically acceptable salt thereof. 2. A method in accordance with claim 1 wherein the compound has the formula or any pharmaceutically acceptable salt thereof. 3. A method in accordance with claim 1 wherein the compound has the formula or any other pharmaceutically acceptable salt of said compound. 4. A method in accordance with claim 1 wherein the compound has the formula or any other pharmaceutically acceptable salt of said compound. 5. A method in accordance with claim 1 wherein the compound has the formula or any other pharmaceutically acceptable salt of said compound. 6. A method in accordance with claim 1 wherein the compound has the formula or any other pharmaceutically acceptable salt of said compound. 7. A method in accordance with claim 1 wherein the compound has the formula or any other pharmaceutically acceptable salt of said compound. 8. A method in accordance with claim 1 wherein the compound has the formula or any other pharmaceutically acceptable salt of said compound. 9. A method in accordance with claim 1 wherein the compound has the formula or any other pharmaceutically acceptable salt of said compound. 10. A method in accordance with claim 1 wherein the compound has the formula or any other pharmaceutically acceptable salt of said compound. 11. A method in accordance with claim 1 wherein said pain is chronic pain. 12. A method in accordance with claim 11 , wherein said chronic pain results from peripheral neuropathy.
Assignees
Inventors
Classifications
Immunomodulators · CPC title
Immunostimulants · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
without antiinflammatory effect · CPC title
Drugs for disorders of the nervous system · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9278943B2 cover?
- The compounds shown by the structural formulas below have analgesic effect and are used in compositions and methods for treating mammal in need of such treatment.
- Who is the assignee on this patent?
- Leblond Bertrand, Beausoleil Eric, Taverne Thierry, and 4 more
- What technology area does this patent fall under?
- Primary CPC classification C07D265/30. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).